ImmunityBio (IBRX) EBT Margin (2014 - 2026)
ImmunityBio's (IBRX) quarterly EBT Margin came in at 1431.45% in Q1 2026, down 64499.0% year-on-year from N/an in Q1 2025, and down 782.6% on a QoQ basis from 162.19% in Q4 2025.
ImmunityBio (IBRX) EBT Margin (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 13 years of EBT Margin data on file, last reported at 1431.45% in Q1 2026.
- On a quarterly basis, EBT Margin fell 64499.0% year-over-year to 1431.45% in Q1 2026; TTM through Mar 2026 was 606.12%, a 70518.0% increase from a year earlier, with the FY2025 full-year figure at 310.37%, up 249496.0% from the prior year.
- EBT Margin for Q1 2026 stood at 1431.45%, down from 162.19% in the prior quarter.
- Over the last five years, EBT Margin for IBRX reached as high as 162.19% in Q4 2025 and fell as low as 735700.0% in Q1 2022.
- Historically, EBT Margin has averaged 132740.67% across 5 years, with a median of 32384.17% in 2023.
- Across the five-year window, EBT Margin slumped 67780432 bps in 2022 and jumped 70331583 bps in 2023, its largest moves.
- Year by year, EBT Margin stood at 148345.21% in 2022, then retreated by 13 bps to 167952.52% in 2023, then soared by 100 bps to 783.62% in 2024, then soared by 79 bps to 162.19% in 2025, then slumped by 783 bps to 1431.45% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 1431.45% in Q1 2026, 162.19% in Q4 2025, and 209.94% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn | -1,431.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,431.45% |
| Dec 31, 2025 | -162.19% |
| Sep 30, 2025 | -209.94% |
| Jun 30, 2025 | -349.31% |
| Mar 31, 2025 | -786.46% |
| Dec 31, 2024 | -783.62% |
| Sep 30, 2024 | -1,404.39% |
| Jun 30, 2024 | -12,854.25% |
| Mar 31, 2024 | -335,325.00% |
| Dec 31, 2023 | -167,952.52% |
| Sep 30, 2023 | -116,636.59% |
| Jun 30, 2023 | -337,104.88% |
| Mar 31, 2023 | -32,384.17% |
| Dec 31, 2022 | -148,345.21% |
| Sep 30, 2022 | -94,204.24% |
| Jun 30, 2022 | -270,957.14% |
| Mar 31, 2022 | -735,700.00% |
| Dec 31, 2021 | -23,474.87% |
| Sep 30, 2021 | -133,983.33% |
| Jun 30, 2021 | -26,366.67% |